Rabion A, Verlhac J B, Fraisse L, Roche B, Seris J L
Laboratoire de Chimie Organique et Organométallique, URA 35 CNRS, Université Bordeaux I, Talence, France.
Free Radic Res Commun. 1993;19(6):409-23. doi: 10.3109/10715769309056530.
A new series of metal ligands containing the 1,3-dimethyl-6-amino-5- nitrosouracil moiety has been synthesized and they have been studied as potential inhibitors of iron-dependent lipid peroxidation. For this purpose, these new derivatives have been tested in the Fenton induced deoxyribose degradation assay, which allows a quantitative measurement of their inhibitory effect towards hydroxyl radical generation. When iron(II) is complexed by these ligands, a strong inhibition of deoxyribose degradation is observed, especially in the case of tris-[2-(1,3-dimethyl-5-nitrosouracil-6-yl)aminoethyl] amine (5). This inhibitory effect is clearly related to a specific complexation of iron(II) and is not due to the direct scavenging of hydroxyl radical by the ligand. Inhibition of the iron mediated Fenton reaction presumably results from inactivation of the reactivity of the metal center towards hydrogen peroxide. These derivatives, as well as long alkyl chain substituted nitrosouracils were evaluated in the protection of biological membranes against lipid peroxidation (induced by iron(II)/dihydroxyfumaric acid and determined with the 2-thiobarbituric acid test). Ligand 5 inhibited lipid peroxidation at a rate similar to Desferal (desferrioxamine B) and slightly higher than bathophenanthroline sulphonate (BPS), which are respectively good iron(III) and iron(II) chelators. When covalently bound with a long alkyl chain, the increase of lipophilic character of the ligand allows its location near the mitochondrial membrane, where lipid peroxidation occurs. Lower concentrations (IC50 = 4 microM) are then necessary to inhibit lipid peroxidation. This IC50 concentration should be compared to those obtained for Trolox (IC50 = 3 microM) or the 21-aminosteroid U74500A (IC50 = 1 microM) described previously.
已经合成了一系列含有1,3 - 二甲基 - 6 - 氨基 - 5 - 亚硝基脲部分的新型金属配体,并对其作为铁依赖性脂质过氧化的潜在抑制剂进行了研究。为此,在芬顿诱导的脱氧核糖降解试验中对这些新衍生物进行了测试,该试验能够定量测量它们对羟基自由基生成的抑制作用。当铁(II)与这些配体络合时,观察到对脱氧核糖降解有强烈抑制作用,特别是对于三 - [2 - (1,3 - 二甲基 - 5 - 亚硝基脲 - 6 - 基)氨基乙基]胺(5)。这种抑制作用显然与铁(II)的特定络合有关,而不是由于配体直接清除羟基自由基。铁介导的芬顿反应的抑制可能是由于金属中心对过氧化氢的反应性失活所致。这些衍生物以及长烷基链取代的亚硝基脲在保护生物膜免受脂质过氧化(由铁(II)/二羟基富马酸诱导,并通过2 - 硫代巴比妥酸试验测定)方面进行了评估。配体5抑制脂质过氧化的速率与去铁胺(去铁胺B)相似,略高于邻二氮菲磺酸盐(BPS),它们分别是良好的铁(III)和铁(II)螯合剂。当与长烷基链共价结合时,配体亲脂性的增加使其能够定位在线粒体膜附近,脂质过氧化在此发生。然后抑制脂质过氧化需要较低的浓度(IC50 = 4 microM)。该IC50浓度应与之前描述的生育三烯酚(IC50 = 3 microM)或21 - 氨基类固醇U74500A(IC50 = 1 microM)的浓度进行比较。